Single anti-strong companies have the most market
Custom Synthesis, Antibody drugs, cell therapy and gene therapy have become the three key areas of biotechnology development in the future. The FDA has so far approved more than 70 monoclonal antibody drugs, and the global antibody drug market has grown rapidly, becoming one of the most important categories of biological drugs.
The global market for single resistance expanded rapidly from $53 billion trillion in 2012 to $88 billion in 2016, reaching $49 billion in the first half of 2017 and continuing to grow in market share. The global single resistance market is expected to break through the billion dollar mark for the first time in 2017. According to professional forecasts, by 2025 more than 150 antibodies will be listed, when the global antibody drugs will be more than 300 billion U.S. dollars annual sales.
According to the global best-selling drug data statistics, 2016 the world’s best-selling 10 drugs in 8 biological drugs, of which 5 are monoclonal, respectively, adalimumab, EF xidan anti-, trastuzumab single resistance, Yi-yi-yi, the single resistance. Antibody drug market concentration is high, Roche, Aibevil, Johnson, hundred times the United States, Novartis, MSD 6 Enterprises accounted for 80% of the market share, the total annual sales of more than 20 billion U.S. dollars.
Single-resistant drugs have become the fastest growing segment of the global biopharmaceutical industry, with more than 5 billion dollars worth of blockbuster drugs in recent years. And look at the domestic market, in foreign multiple single anti-patent protection period, the domestic single resistance into health care after the positive stimulation, China’s single anti-drug also ushered in adequate growth momentum.
At present, there are 22 antibody drugs listed domestically, of which 12 imported drugs account for 80% of the total. Domestic single resistance market is far less than developed countries, there is still a huge space for development. Experts predict that China’s single resistance market in 2020 can reach 28 billion yuan. Single resistance field has become a domestic and foreign drug companies scramble to layout the gold industry, local enterprises are happy enclosure.http://www.haihengpharma.com/single-anti-strong-companies-have-the-most-market/News